BACKGROUND: Tumour permittivity feedback control is a novel method for microwave ablation (MWA) that theoretically allows for larger, more predictable ablations. This prospective case series evaluates the feasibility and efficacy of MWA of liver malignancies using a device with tumour permittivity feedback control. METHODS: Ten consecutive patients initially determined to be candidates for surgical resection of a liver malignancy underwent intra-operative MWA with tumour permittivity feedback control followed by a surgical resection. A 14-gauge Medwaves microwave antenna was used to deliver a single treatment according to the manufacturer's recommendations. Tumours were assessed grossly as well as by haematoxylin and eosin (H&E) and tetrazolium chloride staining. The primary end point was per cent tumour necrosis. RESULTS: The median maximum ablation diameter measured was 4.1 cm (range 3.0-6.8). The median ablation volume was 8.7 cm(3) (range 4.84-17.55). Six of the 10 tumours demonstrated a pathological complete response (CR). Six of seven tumours ≤ 3 cm demonstrated a pathological CR. Zero of the three tumours ≥ 3 cm had a pathological CR, but all had ≥ 50% tumour necrosis. All patients survived and there were no ablation-related morbidities. DISCUSSION: MWA of liver tumours with tumour permittivity feedback control is feasible and appears effective for the treatment of small (< 3 cm) liver tumours.
BACKGROUND:Tumour permittivity feedback control is a novel method for microwave ablation (MWA) that theoretically allows for larger, more predictable ablations. This prospective case series evaluates the feasibility and efficacy of MWA of liver malignancies using a device with tumour permittivity feedback control. METHODS: Ten consecutive patients initially determined to be candidates for surgical resection of a liver malignancy underwent intra-operative MWA with tumour permittivity feedback control followed by a surgical resection. A 14-gauge Medwaves microwave antenna was used to deliver a single treatment according to the manufacturer's recommendations. Tumours were assessed grossly as well as by haematoxylin and eosin (H&E) and tetrazolium chloride staining. The primary end point was per cent tumour necrosis. RESULTS: The median maximum ablation diameter measured was 4.1 cm (range 3.0-6.8). The median ablation volume was 8.7 cm(3) (range 4.84-17.55). Six of the 10 tumours demonstrated a pathological complete response (CR). Six of seven tumours ≤ 3 cm demonstrated a pathological CR. Zero of the three tumours ≥ 3 cm had a pathological CR, but all had ≥ 50% tumour necrosis. All patients survived and there were no ablation-related morbidities. DISCUSSION: MWA of liver tumours with tumour permittivity feedback control is feasible and appears effective for the treatment of small (< 3 cm) liver tumours.
Authors: S Seki; H Sakaguchi; H Kadoya; H Morikawa; D Habu; S Nishiguchi; S Shiomi; T Kitada; T Kuroki Journal: Endoscopy Date: 2000-08 Impact factor: 10.093
Authors: K Ohmoto; I Miyake; M Tsuduki; N Shibata; M Takesue; T Kunieda; S Ohno; M Kuboki; S Yamamoto Journal: Hepatogastroenterology Date: 1999 Sep-Oct
Authors: José Irving Hernández; Mario Francisco Jesús Cepeda; Francisco Valdés; Geshel David Guerrero Journal: Onco Targets Ther Date: 2015-07-06 Impact factor: 4.147
Authors: Shanda H Blackmon; Rosalie M Sterner; Patrick W Eiken; Thomas J Vogl; Bradley B Pua; Jeffrey L Port; Damian E Dupuy; Matthew R Callstrom Journal: J Thorac Dis Date: 2021-12 Impact factor: 2.895